Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
203 results
  1. pdfNLM Associate Fellowship Project Report: Enhancing 'safety' and 'case report' search filters applied in MEDLINE to ... 
    https://www.nlm.nih.gov/.../NortonPharmacovigilanceSearch2017.pdf
    ... MEDLINE to support PubMed/EMERALD Literature ‘Alerts’ for pharmacovigilance Candace Norton, NLM Associate Fellow 2016-2017 August ... Discussion...................................................................... ........................................................................ ......10 Acknowledgements ....................................................................... ... ...12 Norton 2017 Pharmacovigilance 2 Abstract Objective This project, “Enhancing 'safety' and ' ...
  2. Research Awards, 2004 - Present 
    https://www.nlm.nih.gov/ep/AwardsResearch.html
    ... Laboratory Gonzalez Hernandez, Graciela Social Media Mining for Pharmacovigilance 2 R01 LM011176-06A1 University of Pennsylvania Hoen, ... Rbhs -cancer Institute of New Jersey Friedman, Carol Pharmacovigilance Methods: Leveraging Heterogeneous Adverse Drug Reaction Data 4 ...
  3. Excluded clinical studies - Drug Allergy - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK274133
    ... MC, Dumas F, Demoly P. Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions. Archives of ... in systematic review Machado D, Gomes E. Are pharmacovigilance algorithms trustful for the diagnosis of drug hypersensitivity? ...
  4. Adverse Event Detection, Processing, and Reporting - Registries for Evaluating Patient Outcomes - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK208615
    ... product directly to FDA. As standard practice in pharmacovigilance, many sponsors report events potentially associated with another ... the product development cycle and as part of pharmacovigilance; however, other coding systems are also used. For ...
  5. pdf2012 NLM Training Conference 
    https://www.nlm.nih.gov/.../TC2012TrainingConferenceBook.pdf
    ... Analysis of Drug Induced Gene Expression (Fernald - Stanford) • Pharmacovigilance and Drug Repurposing Model and Application: A Case ... Accounting for Sparse Data in the Training Set Pharmacovigilance and Drug Repurposing Model and Application: A Case ...
  6. Digital Health and Patient Registries: Today, Tomorrow, and the Future - 21st Century Patient Registries - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK493822
    ... technologies are being used to perform disease and pharmacovigilance surveillance. Recently, in Cambodia, mobile phone-based, SMS text messages were used to conduct pharmacovigilance on 17 different vaccines. 30 Their intention was ...
  7. NLM Informatics Training Conference 2012 
    https://www.nlm.nih.gov/ep/trainingconf2012.html
    ... Presentation June 26, 2012 Krystl Haerian Columbia University Pharmacovigilance and Drug Repurposing Model and Application: A Case ... 1 Abstract: An important component of drug safety, pharmacovigilance, entails detecting the risk of unknown serious adverse ...
  8. Analysis of Linked Registry Data Sets - Registries for Evaluating Patient Outcomes - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK208629
    ... is commonly used as part of a postmarketing pharmacovigilance program related to a biologic or pharmaceutical product ... 84. Rosati K. Using electronic health information for pharmacovigilance: the promise and the pitfalls. J Health Life ...
  9. pdf2016MeshTree.pdf 
    https://www.nlm.nih.gov/mesh/2016/download/2016MeshTree.pdf
    ... Phase IV as Topic E05.337.800.600...........................................Pharmacovigilance E05.337.820...........................................Program Evaluation E05.337.851........................................... ...
  10. pdf2017MeshTreesWithChangesShown.pdf 
    https://www.nlm.nih.gov/.../2017MeshTreesWithChangesShown.pdf
    ... Reporting Systems Clinical Trials, Phase IV as Topic Pharmacovigilance Program Evaluation Reproducibility of Results Dimensional Measurement Accuracy ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · next · last